Arkolith/Insider Trading/EMMA/Form 4

Niihara Yutaka

Chairman and CEO, Director, 10% OwnerEmmaus Life Sciences, Inc. (EMMA) · full profile →Form 4 · filed Jan 17, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 12, 2023Grant(A)7.5M$4.50$33.8M0

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-003457) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML